Osteoporosis Secondary Prevention of Fracture in Post Menopausal Women CA5151 V2

Preview

download Osteoporosis Secondary Prevention of Fracture in Post Menopausal Women CA5151 V2
Download

Overview

To provide guidance on the secondary prevention of low energy fracture in post menopausal women with known or suspected osteoporosis.

To standardise and unify this aspect of osteoporosis management throughout the NNUH.

To provide clear evidence based up to date guidance on osteoporosis management and secondary fracture prevention.

To reflect and incorporate current national guidance from opinion-leading bodies such as NICE National Osteoporosis Guideline Group NOGG and Royal College of Physicians RCP in osteoporosis management but also to provide guidance on the use of newer agents such as parenteral bisphosphonates teriparatide PTH and denosumab where NICE technology appraisals are available for some agents but not others and while definitive guidance from major national bodies on the use of these agents is awaited.

To reflect newer thinking in the osteoporosis world that has become more widely accepted since some of the existing guidance was written covering issues such as duration of treatment role of repeat DEXA scanning use of bone marker blood tests and the risks/side effects of osteoporosis drugs especially the bisphosphonates such as atypical femoral shaft fracture.

 

Categories
Clinical
Reference
Date Uploaded
07.06.2016
Date Review
07.06.2019
File Size
372Kb


Clinical Guidelines
This guideline has been approved by the Trust's Clinical Guidelines Assessment Panel as an aid to the diagnosis and management of relevant patients and clinical circumstances. Not every patient or situation fits neatly into a standard guideline scenario and the guideline must be interpreted and applied in practice in the light of prevailing clinical circumstances, the diagnostic and treatment options available and the professional judgement, knowledge and expertise of relevant clinicians. It is advised that the rationale for any departure from relevant guidance should be documented in the patient's case notes.
The Trust's guidelines are made publicly available as part of the collective endeavour to continuously improve the quality of healthcare through sharing medical experience and knowledge. The Trust accepts no responsibility for any misunderstanding or misapplication of this document.